SYNCELL today announced the launch of its Global Rapid Access Service Program (GRASP) to help global customers access its novel Microscoop ™ platform to accelerate their spatial proteomics research and development work.
SYNCLL’s Microscoop platform has been under development since 2014 and is currently available through an early access beta-site program in Taiwan and the US. The new GRASP commercial service offering will expand the system access to researchers globally.
The GRASP team will provide customized services based on SYNCELL’s optoproteomics technology workflow. Customers can submit their sample slides to SYNCELL to obtain a sample-to-result service which will include developing a customizedAI pattern recognition algorithm to identify regions of interest, conducting targetted photolabeling with the Microscoop, extracting labeled proteins and using mass spectrometry to obtain proteome data.
Unlike other current spatial proteomics approaches, the Microscoop platform provides precision photolabeling of select structures or cell types to map the complex proteomics landscape. The technology illuminates protein molecules at the subcellular level and provides the ability to capture thousands of proteins in a single run to produce deep contextual protein datasets. Researchers can use the proteomics data to further examine the biological significance of protein functions or interactions in the areas of interest.
“With the rollout of GRASP service program, we aim to provide customized solutions by leveraging our AI image processing and Microcscoop assay expertise to support our customers in their quest to identify proteins in the regions they are interested in under the microscope,” said Jung-Chi Liao, Ph.D.,founder and CEO of SYNCELL.
For more information about GRASP, please contact us at service@syncell.com
About SYNCELL Inc.
SYNCELL is a development stage company with a vision to revolutionize in situ cell biology and biomedical research. The company will soon introduce its groundbreaking Microscoop™ platform, the first and only system that allows users to pick up, identify and quantify thousands of known and unknown proteins in specified cellular and subcellular locations. Microscoop™ is pairing unique imaging and illuminating capabilities with novel photolabeling chemicals to provide deep spatial proteomics insights to transform a wide range of basic biology and translational research including neuroscience, oncology, immunology, infectious disease, gene therapy, and to identify novel therapeutic targets with spatial context to accelerate drug discovery and development programs.
CONTACT:
Shuyi Liao
SYNCELL, Inc.
Phone +886-2-77505632
Info@syncell.com
Follow SYNCELL on LinkedIn at SYNCELL INC. and tag your posts with #syncell or #microscoop
SYNCELL today announced the launch of its Global Rapid Access Service Program (GRASP) to help global customers access its novel Microscoop ™ platform to accelerate their spatial proteomics research and development work.
SYNCLL’s Microscoop platform has been under development since 2014 and is currently available through an early access beta-site program in Taiwan and the US. The new GRASP commercial service offering will expand the system access to researchers globally.
The GRASP team will provide customized services based on SYNCELL’s optoproteomics technology workflow. Customers can submit their sample slides to SYNCELL to obtain a sample-to-result service which will include developing a customizedAI pattern recognition algorithm to identify regions of interest, conducting targetted photolabeling with the Microscoop, extracting labeled proteins and using mass spectrometry to obtain proteome data.
Unlike other current spatial proteomics approaches, the Microscoop platform provides precision photolabeling of select structures or cell types to map the complex proteomics landscape. The technology illuminates protein molecules at the subcellular level and provides the ability to capture thousands of proteins in a single run to produce deep contextual protein datasets. Researchers can use the proteomics data to further examine the biological significance of protein functions or interactions in the areas of interest.
“With the rollout of GRASP service program, we aim to provide customized solutions by leveraging our AI image processing and Microcscoop assay expertise to support our customers in their quest to identify proteins in the regions they are interested in under the microscope,” said Jung-Chi Liao, Ph.D.,founder and CEO of SYNCELL.
For more information about GRASP, please contact us at service@syncell.com
About SYNCELL Inc.
SYNCELL is a development stage company with a vision to revolutionize in situ cell biology and biomedical research. The company will soon introduce its groundbreaking Microscoop™ platform, the first and only system that allows users to pick up, identify and quantify thousands of known and unknown proteins in specified cellular and subcellular locations. Microscoop™ is pairing unique imaging and illuminating capabilities with novel photolabeling chemicals to provide deep spatial proteomics insights to transform a wide range of basic biology and translational research including neuroscience, oncology, immunology, infectious disease, gene therapy, and to identify novel therapeutic targets with spatial context to accelerate drug discovery and development programs.
CONTACT:
Shuyi Liao
SYNCELL, Inc.
Phone +886-2-77505632
Info@syncell.com
Follow SYNCELL on LinkedIn at SYNCELL INC. and tag your posts with #syncell or #microscoop